Should I invest in UTI Medium to Long Duration Fund - Quarterly IDCW?

We don't give personal investment advice. UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW is suitable for an investor whose:time horizon matches the fund's modified duration — short-duration funds for 1-3 year goals, long-duration for 7+ yearsprimary goal is capital preservation or steady accrual, not high growthtax slab is moderate — high-slab investors should evaluate post-tax yield against tax-free alternatives (PPF, tax-free bonds)Cross-check the numbers above against alternatives before deciding. Worst 5-year drawdown: 4.0%. 5-year CAGR: 7.73%.

UTI

UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW

Latest NAV

₹19.5259

As of

24 Jul 2026

4,910 NAV records on file

NAV history & peer comparison

All NAVs split-adjusted and normalised to 100 at the start of the selected period, so funds with very different absolute NAV scales can be compared on one axis.

Period

Add another fund to compare

No matches.

Compares up to 8 funds. Click any line in the legend above to hide/show it.

Returns matrix

Fund return alongside the category average and peer rank for every standard window. Returns under one year are absolute; one year and longer are compound annualised (CAGR).

Window	Fund	Category avg	+/− vs avg	Rank	Quartile
1D	+0.03%	-8.10%	+8.13	62 / 904	Q1
1W	-0.05%	-11.78%	+11.73	385 / 779	Q2
2W	-0.21%	-11.83%	+11.62	387 / 776	Q2
1M	+0.47%	-11.81%	+12.28	103 / 772	Q1
3M	+1.95%	-11.26%	+13.21	59 / 763	Q1
6M	+2.63%	-10.37%	+13.00	148 / 749	Q1
YTD	+2.25%	-10.44%	+12.68	138 / 747	Q1
1Y	+2.93%	-8.22%	+11.15	324 / 728	Q2
2Y	+5.75%	-5.25%	+11.00	245 / 660	Q2
3Y	+6.05%	-3.97%	+10.01	255 / 646	Q2
4Y	+6.43%	+3.36%	+3.06	33 / 136	Q1
5Y	+7.73%	+3.47%	+4.26	9 / 92	Q1
7Y	+5.02%	+3.36%	+1.65	38 / 76	Q2
10Y	+3.59%	+3.80%	-0.20	38 / 66	Q3
Inception	+2.97%	-1.10%	+4.07	468 / 904	Q3

Quartile legend: Q1 top 25% Q2 25-50% Q3 50-75% Q4 bottom 25%

Calendar-year returns

Full-year performance vs category average. Current year is partial (year-to-date).

Year	Fund	Category avg	+/− vs avg	Rank
2026 YTD	+2.25%	+0.22%	+2.02	21 / 49
2025	+5.72%	+2.91%	+2.81	22 / 61
2024	+8.55%	+5.21%	+3.34	8 / 62
2023	+6.33%	+3.66%	+2.67	29 / 69
2022	+8.20%	-8.21%	+16.41	12 / 224
2021	+6.10%	-6.85%	+12.95	21 / 355
2020	-1.22%	+3.44%	-4.65	384 / 433
2019	-5.86%	+4.28%	-10.13	414 / 449
2018	+2.90%	+0.48%	+2.41	120 / 205
2017	-1.52%	+1.61%	-3.13	170 / 223
2016	+8.43%	+3.44%	+4.99	71 / 223

Rolling returns

Removes start-date bias by averaging CAGR over every overlapping N-year window in the fund's history. Higher average plus tight min/max plus high "% positive" = consistent.

1-Year rolling

+3.02%

236 windows

min -10.9% · max 14.6%

77% positive

3-Year rolling

+2.91%

211 windows

min -3.4% · max 10.0%

85% positive

5-Year rolling

+2.72%

187 windows

min -0.9% · max 7.7%

95% positive

7-Year rolling

+2.48%

163 windows

min 0.4% · max 5.2%

100% positive

SIP returns — historical "what if"

If you had invested every month in this fund over the chosen period, this is what your investment would be worth today.

Period

Total invested

₹ —

Today's value

₹ —

XIRR

Annualised

Wealth multiplier

Period	Total invested	Today's value	XIRR	Wealth multiplier

XIRR is the annualised internal rate of return on the SIP cash flow — invariant to the monthly amount. "Today's value" and "Total invested" scale linearly with the slider. Past performance does not guarantee future returns. Excludes exit load and taxes.

Risk profile

Risk-adjusted return and volatility, computed from monthly NAV returns over the trailing 3-year and 5-year windows.

Std deviation

2.44%

3-year · annualised

Sharpe ratio

-0.25

vs risk-free 6.5%

Sortino ratio

-0.62

Downside-only deviation

Max drawdown

-1.73%

May 2025 → Aug 2025

% positive months

80.6%

Share of monthly returns > 0 over the 3-year window

Sharpe / Sortino use a risk-free rate of 6.5% (1-year T-bill proxy). Higher Sharpe = more return per unit of total risk; higher Sortino = more return per unit of downside risk.

Peers in Medium to Long Duration Fund

Scheme	Fund house	NAV	As of
HDFC Charity Fund for Cancer Cure - IDCW Option - 50% IDCW Donation Option	HDFC	₹10.1274	24 Jul 2026
NIPPON INDIA FIXED MATURITY PLAN - XLI - SERIES 8 - IDCW Option	Nippon India	₹17.3421	24 Jul 2026
SBI Medium to Long Duration Fund - Regular Plan - Half Yearly - Income Distribution cum Capital Withdrawal Option (IDCW)	SBI	₹19.2650	24 Jul 2026
ICICI Prudential Bond Fund - Half Yearly IDCW	ICICI Prudential	₹11.3242	24 Jul 2026
Franklin India Medium to Long Duration Fund - IDCW	Franklin India	₹10.5957	24 Jul 2026
CANARA ROBECO INCOME FUND - REGULAR PLAN - GROWTH OPTION	Canara Robeco	₹56.8943	24 Jul 2026
UTI Annual Interval Fund - I - ( Instn Growth Option )	UTI	₹37.7361	24 Jul 2026
Aditya Birla Sun Life Income Fund - Growth - Regular Plan	Birla Sun Life	₹129.7040	24 Jul 2026
Bandhan Medium to Long Duration Fund - Regular Plan - Annual IDCW	IDFC	₹11.9309	24 Jul 2026
JM Medium to Long Duration Fund (Regular) - Bonus Option- Principal Units	JM Financial	₹26.3635	24 Jul 2026

Recent NAVs

Date	NAV
24 Jul 2026	₹19.5259
23 Jul 2026	₹19.5207
22 Jul 2026	₹19.5318
21 Jul 2026	₹19.5461
20 Jul 2026	₹19.5315
17 Jul 2026	₹19.5356
16 Jul 2026	₹19.5437
15 Jul 2026	₹19.5236
14 Jul 2026	₹19.5093
13 Jul 2026	₹19.5688

Frequently asked questions

These answers are generated from this fund's live metrics — NAV, returns, peer rank, drawdown, SIP backtest. Numbers refresh nightly after AMFI's NAV feed lands.

As of 24 Jul 2026, the NAV of UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW is ₹19.5259. It's a Medium to Long Duration Fund from UTI, run as a Unknown plan IDCW (dividend) option. NAVs update once per business day from the AMFI feed.

UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW has NAV history starting from 03 Apr 2006, a track record of about 20 years 3 months. Long-tenured funds like this have weathered multiple market cycles — the 2008 crash, 2013 taper tantrum, 2020 COVID drawdown — which makes their returns more credible than a 3-year track record alone.

UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW is managed by UTI. It's classified by AMFI under the 'Medium to Long Duration Fund' SEBI category, which determines its peer set and tax treatment.

Over the trailing 1-year window, UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW has delivered a absolute return of 2.93% — +11.15 pp ahead of the Medium to Long Duration Fund category average of -8.22%. The fund ranks #324 of 728 in its category — the second (Q2) quartile.

Over the trailing 3-year window, UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW has delivered a CAGR of 6.05% — +10.01 pp ahead of the Medium to Long Duration Fund category average of -3.97%. The fund ranks #255 of 646 in its category — the second (Q2) quartile.

Over the trailing 5-year window, UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW has delivered a CAGR of 7.73% — +4.26 pp ahead of the Medium to Long Duration Fund category average of 3.47%. The fund ranks #9 of 92 in its category — the top (Q1) quartile.

₹1 lakh invested in UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW exactly 10 years ago would be worth approximately ₹142,320 today — a multiplier of 1.42×, based on the 10-year CAGR of 3.59%. The category average over the same window would have grown ₹1 lakh to ₹145,151.

A ₹10,000 monthly SIP in UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW over the last 5 years — total invested ₹600,000 — would be worth ₹704,284 today. That's an XIRR (money-weighted annualised return) of 6.34%.

A ₹10,000 monthly SIP for 10 years in UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW = ₹1,200,000 invested. It would currently be worth ₹1,539,553 (multiplier 1.28×). XIRR: 4.87%. Long-horizon SIP results matter more than point-to-point returns because they smooth out entry timing.

On a 5-year basis, UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW ranks #9 out of 92 funds in the Medium to Long Duration Fund category — that places it in the top quartile (Q1) — strong outperformance. The category average return over the same window is 3.47%; this fund delivered 7.73%.

The worst peak-to-trough decline UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW has experienced over the last 5-year window is 4.01% — its NAV fell from a high on 14 Dec 2021 to a low on 05 May 2022. Drawdown is a useful gauge of how much short-term pain you'd have endured to capture the long-term return.

Across all 5-year rolling windows, UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW averaged 2.72% (best 7.73%, worst -0.95%). 95% of rolling windows ended positive. The 5-year Sharpe ratio is 0.25 — weak risk-adjusted performance.

In calendar year 2025, UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW returned 5.72% — beating the Medium to Long Duration Fund category average of 2.91% by 2.81 pp. It ranked #22 of 61 in its category that year.

UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW is classified as a Debt fund. For units acquired on or after 1 April 2023, all gains are taxed at your income-tax slab rate regardless of holding period — there's no LTCG concession or indexation. For pre-April-2023 units, the old rules with indexation still apply on long-term gains.

We don't give personal investment advice. UTI Medium to Long Duration Fund - Regular Plan - Quarterly IDCW is suitable for an investor whose:

time horizon matches the fund's modified duration — short-duration funds for 1-3 year goals, long-duration for 7+ years
primary goal is capital preservation or steady accrual, not high growth
tax slab is moderate — high-slab investors should evaluate post-tax yield against tax-free alternatives (PPF, tax-free bonds)

Cross-check the numbers above against alternatives before deciding. Worst 5-year drawdown: 4.0%. 5-year CAGR: 7.73%.

Educational content only — not investment advice. Tax rules summarised above reflect Budget 2024; consult a qualified adviser before transacting.